Most clinical scientific tests accept the position of drugs modulating by means of NMDA receptors. Ketamine is noncompetitive voltage-dependent NMDA-receptor channel blocker whose antidepressant action is obvious at reduced doses, and with raising doses, it mimics psychotomimetic action and sooner or later contributes to anesthesia in higher doses.… Read More